Trial intelligence / Profile preview

IV Monofer vs placebo in iron-deficient first-time female blood donors

2012-001529-28Phase 3Completed

Sponsor
Pharmacosmos
Start
May 2012
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Monofer arm with Placebo arm (2 arms). Primary endpoint: Change in hemoglobin concentration. Started May 2012; status: completed.

02

Drugs

ferric derisomaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2012-001529-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001529-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call